Cartiva Implant Lawyers of HLF

A Division of The Hurwitz Law Firm PC · Defective Toe Implant Attorneys

Need a Cartiva implant lawyer?

Call Now: (888) 510-9251

Hotline Open 24 Hours

Our Cartiva implant lawyers file toe replacement lawsuits for arthritis patients requiring corrective surgery. Toe implant lawsuits claim Cartiva failed to properly design this synthetic cartilage device.

As such, arthritis patients who received a defective Cartiva toe implant may be eligible to claim a cash settlement.


Cartiva Lawyers Advocate for Toe Implant Victims

Our team of Cartiva attorneys have represented thousands of victims of dangerous medical implants. In doing so, we have recovered millions of dollars in settlement funds on their behalf.

However, we only pursue compensation from the device manufacturers and their affiliates, and do not file claims against our clients’ doctors or hospitals.


No Legal Fee Unless You Obtain a Settlement

While compensation may be available to qualified arthritis surgery claimants, victims are urged to act promptly. The #1 claim Cartiva implant lawyers can make for toe compensation is one filed within the Statute of Limitations. Follow this link for our latest information on the Cartiva multi-district litigation (MDL).

Our Cartiva implant lawyers are available to review claims now. We offer a free case evaluation to confirm the use of a Cartiva implant and a related surgery or injury. Further, we never charge a legal fee unless a financial recovery is obtained for our client.

Get your Cartiva implant lawsuit review.



What Is the Cartiva Toe Implant?

The Cartiva Synthetic Cartilage Implant (SCI) is a small medical device for big toe arthritis.
Surgeons insert the device to replace damaged joint cartilage and preserve motion.
It uses a polyvinyl alcohol hydrogel that mimics natural cartilage.
The implant received FDA 510(k) clearance in 2016 as a “substantial equivalent” to earlier devices.


What Was the Purpose of the Cartiva Implant?

Cartiva aimed to reduce pain and maintain motion in patients with hallux rigidus, a degenerative big toe condition.
It was marketed as an alternative to toe fusion surgery.
The manufacturer claimed the implant provided durable cushioning and reduced recovery time.


Who Manufactured the Cartiva Toe Implant?

Cartiva Inc., based in Alpharetta, Georgia, developed and marketed the device.
In 2018, Stryker Corporation, a global orthopedic company, acquired Cartiva Inc.
Stryker continued selling the implant under its own product line after acquisition.


Why Are Patients Filing Cartiva Implant Lawsuits?

Patients allege that the Cartiva toe implant failed prematurely.
They report intense pain, swelling, joint collapse, and implant migration.
Many required revision surgeries or full toe fusion after implant failure.
Cartiva implant lawsuits claim Stryker and Cartiva misrepresented the product’s durability and safety.


What Defects Are Alleged in the Cartiva Implant Lawsuits?

Material Shrinkage

The hydrogel implant loses volume, causing joint collapse.

Loss of Integrity

The device may crack or disintegrate over time.

Bone Resorption

The implant’s failure damages surrounding bone tissue.

Chemical Breakdown

Hydrogel instability leads to inflammation and tissue reaction.

Cartiva implant lawyers cite internal testing suggesting premature degradation under mechanical stress.


What Is the Cartiva Toe Implant Recall?

No official FDA recall has been issued, but surgeons report widespread product failures.
Medical alerts and field safety notices function like a de facto Cartiva toe implant recall.
Stryker faces growing scrutiny over device safety and post-market monitoring failures.
Toe implant lawyers track regulatory developments and device alerts daily.


What Injuries Result From Failed Cartiva Implants?

  • Severe toe pain and stiffness.

  • Joint collapse or deformity.

  • Bone loss or osteolysis.

  • Implant migration or extrusion.

  • Infection or inflammatory response.

  • Need for revision surgery or arthrodesis.

Many plaintiffs describe permanent disability or mobility impairment following failure.


What Is the Scientific Problem With Cartiva’s Hydrogel?

Cartiva’s hydrogel absorbs water but weakens under repetitive load.
The material’s elastic modulus decreases under cyclic stress, reducing shock absorption.
Hydration imbalance leads to surface fissures, particle shedding, and mechanical collapse.
Histology often shows fibrotic tissue surrounding degraded hydrogel fragments.

Cartiva implant lawsuits use biomedical experts to explain polymer fatigue and microfracture mechanisms.


How Does FDA Regulation Apply to the Cartiva Implant?

Cartiva received 510(k) clearance, not premarket approval (PMA).
This means the FDA accepted the device as substantially equivalent to older implants.
Manufacturers did not conduct full clinical safety trials before approval.
Cartiva toe implant lawyers argue that limited regulatory oversight allowed defective materials to reach patients.


What Role Did Stryker Play in Cartiva Implant Distribution?

Stryker acquired Cartiva and integrated it into its orthopedic portfolio.
After the Cartiva toe implant recall controversy, Stryker assumed legal exposure for product claims.
Stryker’s marketing emphasized durability, though internal documents allegedly warned of performance issues.
Toe implant lawyers investigate whether Stryker continued distribution despite known failure rates.


How Common Is Cartiva Implant Failure?

Clinical studies suggest failure rates between 30% and 50% within five years.
Symptoms often reappear within 12 months after surgery.
Failures include implant subsidence, bone loss, and loss of range of motion.
Cartiva implant lawsuits cite these outcomes as evidence of design defect.


How Do Cartiva Lawyers Prove Device Defect?

Cartiva implant lawyers use engineering, medical, and forensic analysis.
They examine retrieved implants under microscopy to show shrinkage or cracking.
They use finite element modeling to demonstrate stress points exceeding material tolerance.
Experts testify about polymer fatigue, biomechanical instability, and material failure under load.


What Legal Theories Support Cartiva Toe Implant Lawsuits?

Design Defect

The hydrogel material lacked adequate durability.

Manufacturing Defect

Inconsistent production caused variable porosity and failure.

Failure to Warn

Patients and surgeons lacked adequate risk information.

Negligence

Stryker continued sales despite internal warnings.

Breach of Warranty

Marketing claims misrepresented safety and longevity.


What Evidence Strengthens a Cartiva Implant Lawsuit?

  • Surgical records and operative reports.

  • Device lot and serial numbers.

  • Pre- and post-op X-rays or MRI scans.

  • Surgeon correspondence confirming implant failure.

  • Revision surgery documentation.

  • Product packaging retained after surgery.

Cartiva toe implant lawyers use these records to prove causation and identify defective lots.


How Do Cartiva Implant Lawyers File Claims?

Cartiva lawyers file product liability suits in state or federal courts.
They collect medical evidence and engage experts in orthopedics and biomaterials.
They coordinate claims through multidistrict litigation (MDL) if consolidation occurs.
They negotiate settlements or proceed to trial depending on case strength.


What Compensation Can Victims Seek?

Victims may recover:

  • Medical and surgical costs.

  • Rehabilitation expenses.

  • Lost wages and earning capacity.

  • Pain, suffering, and emotional distress.

  • Permanent disability compensation.

Some Cartiva implant lawsuits may include punitive damages for reckless conduct.


What Are the Signs of a Failing Cartiva Implant?

  • Sharp pain while walking.

  • Toe stiffness or reduced motion.

  • Clicking or grinding sensation.

  • Swelling and redness around the joint.

  • X-ray evidence of implant migration.
    Immediate evaluation helps preserve evidence for future Cartiva toe implant lawsuits.


What Scientific Testing Supports Lawsuit Claims?

Independent labs perform differential scanning calorimetry (DSC) to test polymer degradation.
Scanning electron microscopy (SEM) reveals microcracks and deformation.
Dynamic mechanical analysis (DMA) measures loss of elasticity and strength.
These results often confirm hydrogel fatigue under normal biomechanical stress.


What Did Postmarket Surveillance Reveal?

Surgeons reported recurrent implant failures to the MAUDE database.
Adverse event summaries mention subsidence, pain, and mechanical breakdown.
Cartiva implant lawyers use FDA records to demonstrate foreseeable risk.


What Legal Actions Are Currently Pending?

Multiple Cartiva implant lawsuits are active in federal and state courts.
Attorneys expect future consolidation into a mass tort or MDL.
Plaintiffs continue to file across the United States citing uniform design failure.
Toe implant lawyers monitor court filings and pretrial motions nationwide.


What Is the Role of Stryker in Ongoing Litigation?

Stryker, as the parent company, inherits Cartiva’s legal liabilities.
Plaintiffs name Stryker in suits for marketing and continued distribution.
Cartiva toe implant lawyers pursue Stryker for corporate negligence and concealment of device risks.


How Long Do Patients Have To File a Cartiva Lawsuit?

Statutes of limitation vary by state, usually two to four years.
The clock starts when patients discover injury or device failure.
Prompt consultation with a Cartiva implant lawyer preserves eligibility.


What Should Patients Do If Their Cartiva Implant Failed?

  • Request full surgical and hospital records.

  • Obtain revision surgery reports.

  • Preserve the removed implant for analysis.

  • Contact a Cartiva toe implant lawyer immediately.
    Fast action ensures evidence preservation and timely claim filing.


How Can a Cartiva Lawyer Help?

Cartiva implant lawyers investigate claims, gather scientific data, and negotiate fair settlements.
They connect clients with medical experts to evaluate long-term harm.
They manage communication with Stryker’s defense counsel and insurers.
They guide victims through litigation and possible trial.


What Is the Expected Outcome of Cartiva Litigation?

Settlements may reach significant compensation if systemic design flaws are proven.
Precedents from other orthopedic device cases suggest multimillion-dollar recoveries.
Court outcomes depend on evidence, medical causation, and expert credibility.


What Makes Cartiva Cases Scientifically Unique?

The implant fails from hydrogel fatigue rather than metal or plastic fracture.
This makes Cartiva lawsuits highly dependent on polymer science and materials analysis.
Attorneys collaborate with biomechanical engineers and polymer chemists to prove causation.